Cargando…
SARS-CoV-2 and Fetal Inflammation
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
New York, Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970584/ http://dx.doi.org/10.1016/S1751-4851(22)00061-7 |
Ejemplares similares
Ejemplares similares
-
Neuropsychiatric disorders following SARS-CoV-2 infection
por: Harrison, Paul J, et al.
Publicado: (2023) -
Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial
por: Ashraf, Sohaib, et al.
Publicado: (2022) -
CT presentations of adult and pediatric SARS-CoV-2 patients: A review of early COVID-19 data()
por: Waller, J.V., et al.
Publicado: (2021) -
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial
por: Brakenhoff, Timo B., et al.
Publicado: (2021) -
Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction
por: Pels, Anouk, et al.
Publicado: (2019)